| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52660-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75189-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20156-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12036-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50284-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47958-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | MAB6333-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47906-0.1mg | |||
| IHC-Prediluted | NBP2-48271 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26540-50ul | |||
![Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - CD25/IL-2 R alpha Antibody (Daclizumab) [NBP2-52660] - Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Daclizumab (NBP2-52660, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Chimeric-Flow-Cytometry-NBP2-52660-img0006.jpg "Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - CD25/IL-2 R alpha Antibody (Daclizumab) [NBP2-52660] - Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Daclizumab (NBP2-52660, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - Cynomolgus monkey lymphocytes were stained with an isotype control (red) or the rabbit-chimeric version of Daclizumab (NBP2-52660, blue) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody (ab150073) and cells analysed on a FlowJo single-cell flow cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Chimeric-Flow-Cytometry-NBP2-52660-img0004.jpg)
![Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - CD25/IL-2 R alpha Antibody (Daclizumab) [NBP2-52660] - Rhesus monkey lymphocytes were stained with an isotype control (red) or the rabbit-chimeric version of Daclizumab (NBP2-52660, blue) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody (ab150073) and cells analysed on a FlowJo single-cell flow cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Chimeric-Flow-Cytometry-NBP2-52660-img0005.jpg)
![Flow Cytometry: Siglec-2/CD22 Antibody (hL22 (Epratuzumab)) - Chimeric [NBP2-75189] - Flow-cytometry using anti-CD22 antibody Epratuzumab. Rhesus monkey lymphocytes were stained with an isotype control (NBP2-52636, panel A) or the rabbit-chimeric version of Epratuzumab (NBP2-75189, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-hL22-Epratuzumab-Chimeric-Flow-Cytometry-NBP2-75189-img0003.jpg "Flow Cytometry: Siglec-2/CD22 Antibody (hL22 (Epratuzumab)) - Chimeric [NBP2-75189] - Flow-cytometry using anti-CD22 antibody Epratuzumab. Rhesus monkey lymphocytes were stained with an isotype control (NBP2-52636, panel A) or the rabbit-chimeric version of Epratuzumab (NBP2-75189, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: Siglec-2/CD22 Antibody (hL22 (Epratuzumab)) - Chimeric [NBP2-75189] - Flow-cytometry using anti-CD22 antibody Epratuzumab. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Eptratuzumab (NBP2-75189, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-hL22-Epratuzumab-Chimeric-Flow-Cytometry-NBP2-75189-img0001.jpg)
![Flow Cytometry: Siglec-2/CD22 Antibody (hL22 (Epratuzumab)) - Chimeric [NBP2-75189] - Flow-cytometry using anti-CD22 antibody Epratuzumab. Cynomolgus monkey lymphocytes were stained with an isotype control (NBP2-52636, panel A) or the rabbit-chimeric version of Epratuzumab (NBP2-75189, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-hL22-Epratuzumab-Chimeric-Flow-Cytometry-NBP2-75189-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: NKG2D/CD314 Antibody (6E5A7) - Chimeric - Azide and BSA Free [NBP3-20156] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes stained with the chimeric rabbit IgG version of 6E5A7 (NBP3-20156) (1:1000 dilution) for 1h followed by Alexa Fluor(R) 488 secondary antibody (1:1500 dilution), showing nuclear staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-20156, DAPI, merged channels and an isotype control. The isotype control was anti-fluorescein antibody (NBP2-52638) followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-20156_rabbit-nkg2d-cd314-mab-6e5a7-chimeric-azide-bsa-free-2742023924240.png "Immunocytochemistry/Immunofluorescence: NKG2D/CD314 Antibody (6E5A7) - Chimeric - Azide and BSA Free [NBP3-20156] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes stained with the chimeric rabbit IgG version of 6E5A7 (NBP3-20156) (1:1000 dilution) for 1h followed by Alexa Fluor(R) 488 secondary antibody (1:1500 dilution), showing nuclear staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-20156, DAPI, merged channels and an isotype control. The isotype control was anti-fluorescein antibody (NBP2-52638) followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Western Blot: NKG2D/CD314 Antibody (6E5A7) - Chimeric - Azide and BSA Free [NBP3-20156] - K562(A) (2ug/ml) and human peripheral blood monocytes(B) (2ug/ml) cells lysate (35ug protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of 6E5A7 (NBP3-20156) before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp3-20156_rabbit-nkg2d-cd314-mab-6e5a7-chimeric-azide-bsa-free-2742023924251.png)
![Western Blot: CD98 Antibody (RL388) - Chimeric [NBP3-12036] - Mouse fetal liver lysate (35ug protein in RIPA buffer) was resolved on an SDS PAGE gel and blots probed with the chimeric rabbit IgG version of RL388 (NBP3-12036) at 0.05 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.](http://images.novusbio.com/fullsize/CD98-Antibody-RL388-Chimeric-Western-Blot-NBP3-12036-img0001.jpg "Western Blot: CD98 Antibody (RL388) - Chimeric [NBP3-12036] - Mouse fetal liver lysate (35ug protein in RIPA buffer) was resolved on an SDS PAGE gel and blots probed with the chimeric rabbit IgG version of RL388 (NBP3-12036) at 0.05 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.")
![Immunocytochemistry /Immunofluorescence: CD98 Antibody (RL388) - Chimeric - Azide and BSA Free [NBP3-12036] - Immunofluorescence analysis of paraformaldehyde fixed mouse splenocytes immobilized on Shi-fix(TM) cover-slips and stained with NBP3-12036 at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12036, DAPI, merged channels and an isotype control. The isotype control was stained with anti-Fluorescein antibody (NBP2-52638) followed by Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-12036_rabbit-monoclonal-cd98-antibody-rl388-chimeric-74202522141236.png)
![Western Blot: CD40/TNFRSF5 Antibody (T8P2G4/A6) [NBP2-50284] - Analysis of CD40 in Jurkat cell lysates.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-T8P2G4-A6-Western-Blot-NBP2-50284-img0001.jpg "Western Blot: CD40/TNFRSF5 Antibody (T8P2G4/A6) [NBP2-50284] - Analysis of CD40 in Jurkat cell lysates.")
![Immunohistochemistry-Paraffin: CD40/TNFRSF5 Antibody (T8P2G4/A6) [NBP2-50284] - Analysis of CD40 in a hepatocellular carcinoma tissue cross section.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-T8P2G4-A6-Immunohistochemistry-Paraffin-NBP2-50284-img0002.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (T8P2G4/A6) [NBP2-50284] - Analysis of CD40 in a cross section of human breast cancer tissue. Positive cytoplasmic staining is shown.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-T8P2G4-A6-Immunohistochemistry-NBP2-50284-img0003.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CD44v4/1219) - variant 4 - Azide and BSA Free [NBP2-54581] - Formalin-paraffin human Cervical Squamous Cell Carcinoma stained with CD44v4 Monoclonal Antibody (CD44v4/1219)](http://images.novusbio.com/fullsize/CD44-Antibody-CD44v4-1219-variant-4-Azide-and-BSA-Free-Immunohistochemistry-Paraffin-NBP2-54581-img0001.jpg "Immunohistochemistry-Paraffin: CD44 Antibody (CD44v4/1219) - variant 4 - Azide and BSA Free [NBP2-54581] - Formalin-paraffin human Cervical Squamous Cell Carcinoma stained with CD44v4 Monoclonal Antibody (CD44v4/1219)")
![Immunohistochemistry-Paraffin: CD44 Antibody (CD44v4/1219) - variant 4 - Azide and BSA Free [NBP2-54581] - Formalin-paraffin human Tongue Squamous Cell Carcinoma stained with CD44v4 Monoclonal Antibody (CD44v4/1219)](http://images.novusbio.com/fullsize/CD44-Antibody-CD44v4-1219-variant-4-Azide-and-BSA-Free-Immunohistochemistry-Paraffin-NBP2-54581-img0002.jpg)
![Flow Cytometry: HLA DRA Antibody (169-1B5.2) - Azide and BSA Free [NBP2-47722] - Flow Cytometric Analysis of PFA-fixed Raji cells. HLA DRA Antibody (169-1B5.2) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-169-1B5-2-Azide-and-BSA-Free-Flow-Cytometry-NBP2-47722-img0003.jpg "Flow Cytometry: HLA DRA Antibody (169-1B5.2) - Azide and BSA Free [NBP2-47722] - Flow Cytometric Analysis of PFA-fixed Raji cells. HLA DRA Antibody (169-1B5.2) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).")
![Immunohistochemistry-Paraffin: CD45RB Antibody (PTPRC/1132) - IHC-Prediluted [NBP2-48459] - Formalin-fixed, paraffin-embedded human Lymphoma stained with CD45RB Monoclonal Antibody (PTPRC/1132).](http://images.novusbio.com/fullsize/CD45RB-Antibody-PTPRC-1132-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48459-img0002.jpg "Immunohistochemistry-Paraffin: CD45RB Antibody (PTPRC/1132) - IHC-Prediluted [NBP2-48459] - Formalin-fixed, paraffin-embedded human Lymphoma stained with CD45RB Monoclonal Antibody (PTPRC/1132).")
![Immunohistochemistry-Paraffin: CD45RB Antibody (PTPRC/1132) - IHC-Prediluted [NBP2-48459] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD45RB Monoclonal Antibody (PTPRC/1132).](http://images.novusbio.com/fullsize/CD45RB-Antibody-PTPRC-1132-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48459-img0001.jpg)
![Western Blot: Glutathione S-Transferase mu 1/GSTM1 Antibody (1H7.D8.G5) [NBP2-44180] - Lane 1: rGSTM1 protein. Lane 2: GST. Load: 50 ng per lane. Primary antibody: Mouse anti-GSTM1 Monoclonal Antibody at 1:1,000 overnight at 4C. Secondary antibody: Peroxidase conjugated Rb-a-Ms IgG at 1:40,000 for 30 min at RT. Block for30 min at RT. Predicted/Observed size: 27 kDa, 27 kDa for GSTM1.](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-mu-1-GSTM1-Antibody-1H7-D8-G5-Western-Blot-NBP2-44180-img0002.jpg "Western Blot: Glutathione S-Transferase mu 1/GSTM1 Antibody (1H7.D8.G5) [NBP2-44180] - Lane 1: rGSTM1 protein. Lane 2: GST. Load: 50 ng per lane. Primary antibody: Mouse anti-GSTM1 Monoclonal Antibody at 1:1,000 overnight at 4C. Secondary antibody: Peroxidase conjugated Rb-a-Ms IgG at 1:40,000 for 30 min at RT. Block for30 min at RT. Predicted/Observed size: 27 kDa, 27 kDa for GSTM1.")
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (Ki-1/779) [NBP2-44561] - Formalin-fixed, paraffin-embedded human Hodgkin's Lymphoma stained with CD30/TNFRSF8 Antibody (Ki-1/779).](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-Ki-1-779-Immunohistochemistry-Paraffin-NBP2-44561-img0002.jpg "Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (Ki-1/779) [NBP2-44561] - Formalin-fixed, paraffin-embedded human Hodgkin's Lymphoma stained with CD30/TNFRSF8 Antibody (Ki-1/779).")
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (8F6) [NBP3-26540] - Image of Glutathione S-Transferase pi 1/GSTP1 Antibody (8F6) diluted at 1:100 and staining in paraffin-embedded human kidney tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.](http://images.novusbio.com/fullsize/nbp3-26540_rabbit-glutathione-s-transferase-pi-1-gstp1-mab-8f6-262202415355724.jpg "Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (8F6) [NBP3-26540] - Image of Glutathione S-Transferase pi 1/GSTP1 Antibody (8F6) diluted at 1:100 and staining in paraffin-embedded human kidney tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.")
![Western Blot: Glutathione S-Transferase pi 1/GSTP1 Antibody (8F6) [NBP3-26540] - Positive Western Blot detected in: HepG2 whole cell lysate, Jurkat whole cell lysate, PC-3 whole cell lysate, K562 whole cell lysate, HL-60 whole cell lysate, Mouse Brain whole cell lysate, Rat Brain whole cell lysate. All lanes: Glutathione S-Transferase pi 1/GSTP1 Antibody at 1: 1000 Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 24 kDa Observed band size: 24 kDa](http://images.novusbio.com/fullsize/nbp3-26540_rabbit-glutathione-s-transferase-pi-1-gstp1-mab-8f6-28220241152522.jpg)